(19)
(11) EP 2 569 436 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
30.10.2019 Bulletin 2019/44

(45) Mention of the grant of the patent:
29.11.2017 Bulletin 2017/48

(21) Application number: 11781407.9

(22) Date of filing: 16.05.2011
(51) International Patent Classification (IPC): 
C12N 15/869(2006.01)
A61K 39/12(2006.01)
A61P 35/00(2006.01)
C12N 15/33(2006.01)
A61P 31/12(2006.01)
(86) International application number:
PCT/US2011/036657
(87) International publication number:
WO 2011/143653 (17.11.2011 Gazette 2011/46)

(54)

RECOMBINANT HCMV AND RHCMV VECTORS AND USES THEREOF

REKOMBINANTE HCMV- UND RHCMV-VEKTOREN UND VERWENDUNGEN DAVON

VECTEURS RECOMBINANTS DU HCMV ET DU RHCMV, ET LEURS UTILISATIONS


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 14.05.2010 US 334976 P
25.08.2010 US 376911 P
25.03.2011 WO PCT/US2011/029930

(43) Date of publication of application:
20.03.2013 Bulletin 2013/12

(60) Divisional application:
14162929.5 / 2772265
17197412.4 / 3333265
17205199.7 / 3351636

(73) Proprietor: Oregon Health & Science University
Portland, OR 97239 (US)

(72) Inventors:
  • PICKER, Louis
    Portland OR 97225 (US)
  • NELSON, Jay, A.
    Lake Oswego OR 97034 (US)
  • FRUEH, Klaus
    Portland OR 97229 (US)
  • JARVIS, Michael, A.
    Portland OR 97202 (US)
  • HANSEN, Scott, G.
    Portland OR 97210 (US)

(74) Representative: Predazzi, Valentina et al
Società Italiana Brevetti S.p.A. Piazza di Pietra, 39
00186 Roma
00186 Roma (IT)


(56) References cited: : 
WO-A2-2011/119920
US-A1- 2008 199 493
US-A1- 2009 203 144
US-A1- 2004 086 489
US-A1- 2009 148 477
US-A1- 2009 297 555
   
  • S. G. HANSEN ET AL: "Supporting Online Material to: Evasion of CD8+ T Cells Is Critical for Superinfection by Cytomegalovirus", SCIENCE, vol. 328, no. 5974, 2 April 2010 (2010-04-02), pages 102-106, XP055083803, ISSN: 0036-8075, DOI: 10.1126/science.1185350
  • SCOTT G HANSEN ET AL: "Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, [Online] vol. 15, no. 3, 1 March 2009 (2009-03-01), pages 293-299, XP002695372, ISSN: 1078-8956, DOI: 10.1038/NM.1935 Retrieved from the Internet: URL:http://www.nature.com/nm/journal/v15/n 3/full/nm.1935.html> [retrieved on 2009-02-15]
  • SCOTT G. HANSEN ET AL: "Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine", NATURE, vol. 473, no. 7348, 11 May 2011 (2011-05-11), pages 523-527, XP055082320, ISSN: 0028-0836, DOI: 10.1038/nature10003
  • WANG X ET AL: "Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 77, no. 13, 1 July 2003 (2003-07-01), pages 7182-7192, XP003008533, ISSN: 0022-538X, DOI: 10.1128/JVI.77.13.7182-7192.2003
  • ANDREW J. DAVISON ET AL.: 'New Genes from Old: Redeployment of dUTPase by Herpesviruses.' JOURNAL OF VIROLOGY. vol. 79, no. 20, 2005, pages 12880 - 12892, XP055079250
  • SCOTT G. HANSEN ET AL.: 'Evasion of CD8+ T Cells Is Critical for Superinfection by Cytomegalovirus.' SCIENCE. vol. 328, no. 5974, 02 April 2010, pages 102 - 106, XP002695371
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).